Ddavp Injection
Product Images NDC 55566-2200

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ddavp (NDC 55566-2200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ferring Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Ddavp 01)

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

DDAVP is an injection medication containing desmopressin acetate. Each milliliter of the medication includes 4 mg of desmopressin acetate, 5 mg of chlorobutanol, 9 mg of sodium chloride, and hydrochloric acid for pH adjustment. The medication is refrigerated and intended for intravenous and subcutaneous use only. The dosage instructions can be found on the package insert. This medication is manufactured by Ferring Pharmaceuticals in Parsippany, New Jersey.*

FDA Label Image

Principal Display Panel (Ten 1 mL Ampule Carton)

DDAVP Injection is a medication containing 4g desmopressin acetate, used for intravenous and subcutaneous use only. The medication is stored refrigerated between 2-8°C and comes in ten 1 mL ampules of preservative-free solution. The package includes directions and warnings for use, and the manufacturer is Ferring Pharmaceuticals.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.